Newman Dignan & Sheerar Inc’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Buy
9,455
+3
+0% +$76 0.05% 184
2026
Q1
$239K Buy
9,452
+3
+0% +$77 0.05% 175
2025
Q4
$241K Buy
9,449
+985
+12% +$25.2K 0.05% 173
2025
Q3
$217K Buy
+8,464
New +$215K 0.05% 175

Other funds holding IBDX

Newman Dignan & Sheerar Inc's IBDX Position: Q2 2026 in Review

Newman Dignan & Sheerar Inc increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 0.03% in Q2 2026, buying an estimated $76 and bringing the position to 9,455 shares worth $238K. The position accounts for 0.05% of the portfolio, ranked #184.

Newman Dignan & Sheerar Inc first reported a position in IBDX in Q3 2025 and has held it in 4 quarters since. The position peaked at $241K in Q4 2025. 150 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Newman Dignan & Sheerar Inc held 9,455 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $238K as of Q2 2026.
  • Newman Dignan & Sheerar Inc bought 3 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $76.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 0.05% of Newman Dignan & Sheerar Inc's portfolio in Q2 2026, its #184 holding.
  • Newman Dignan & Sheerar Inc first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q3 2025 and has held it in 4 quarters since.
  • Newman Dignan & Sheerar Inc's iShares iBonds Dec 2032 Term Corporate ETF position peaked at $241K in Q4 2025.
  • 150 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Newman Dignan & Sheerar Inc's 13F filing for Q2 2026, filed 14 Jul 2026.